Encompass Health (NYSE:EHC) Updates FY24 Earnings Guidance

Encompass Health (NYSE:EHC) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $3.86-4.11 for the period, compared to the consensus EPS estimate of $3.98. The company issued revenue guidance of $5.250-5.325 billion, compared to the consensus revenue estimate of $5.25 billion.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on EHC. Mizuho boosted their target price on shares of Encompass Health from $93.00 to $95.00 and gave the company a buy rating in a report on Thursday. Royal Bank of Canada restated an outperform rating and issued a $83.00 target price on shares of Encompass Health in a research note on Friday, February 9th. William Blair reiterated an outperform rating on shares of Encompass Health in a research report on Wednesday, February 7th. Stephens reaffirmed an overweight rating and set a $85.00 price objective on shares of Encompass Health in a research note on Tuesday, January 16th. Finally, Truist Financial raised their price target on shares of Encompass Health from $82.00 to $86.00 and gave the company a buy rating in a report on Friday, February 9th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Encompass Health currently has a consensus rating of Buy and a consensus target price of $84.67.

Encompass Health Stock Performance

NYSE:EHC traded down $0.04 during trading hours on Thursday, reaching $82.76. The company had a trading volume of 524,673 shares, compared to its average volume of 660,172. The firm’s 50 day moving average price is $77.89 and its 200-day moving average price is $70.67. The firm has a market cap of $8.29 billion, a price-to-earnings ratio of 23.57, a PEG ratio of 1.53 and a beta of 0.94. Encompass Health has a 52 week low of $57.55 and a 52 week high of $85.84. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.19. The firm had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. The company’s revenue for the quarter was up 13.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.88 earnings per share. On average, analysts forecast that Encompass Health will post 3.96 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.72%. Encompass Health’s dividend payout ratio is 17.29%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.